Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
23.82
-0.99 (-3.99%)
Aug 29, 2025, 10:49 AM - Market open
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $766.73 million as of August 29, 2025. Its market cap has decreased by -1.32% in one year.
Market Cap
766.73M
Enterprise Value
490.83M
1-Year Change
-1.32%
Ranking
Category
Stock Price
$23.82
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $766.73M, an increase of 370.40%. That is a compound annual growth rate of 120.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 798.59M | 23.77% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.09B |
| Johnson & Johnson | 425.77B |
| AbbVie | 367.55B |
| UnitedHealth Group | 275.22B |
| AstraZeneca | 248.07B |
| Novo Nordisk | 246.45B |
| Novartis AG | 245.68B |
| Abbott Laboratories | 228.80B |